Robert Gantt, MD
Anesthesiology · Savannah, GANPI 1407888043
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 35.0% of the total. Reporting peaked in 2023 at $438 and has fallen 71.5% since, to $125 in 2025. Among anesthesiology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 87 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$537
- Johnson & Johnson$295
- Takeda Pharmaceuticals U.S.A., Inc.$147
- Merck$109
- Regeneron Healthcare Solutions, Inc.$78
- Ferring Pharmaceuticals Inc.$68
- plus $298 from 13 others
What the payments were for
- Food & beverage$1,532100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 33 | $537 |
| Johnson & Johnson | 17 | $295 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $147 |
| Merck | 6 | $109 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
| Ferring Pharmaceuticals Inc. | 3 | $68 |
| QOL Medical, LLC | 2 | $61 |
| Mylan Institutional Inc. | 2 | $38 |
| Nestle Healthcare Nutrition Inc. | 2 | $35 |
| Boston Scientific | 2 | $27 |
| Amgen | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Madrigal Pharmaceuticals | 1 | $19 |
| AstraZeneca | 1 | $15 |
| Intercept Pharmaceuticals, Inc. | 1 | $15 |
| Baxter Healthcare | 1 | $14 |
| Shire North American Group Inc | 1 | $13 |
| Shionogi Inc | 1 | $12 |
| VBI Vaccine (delaware) Inc. | 1 | $12 |
How this compares
$1,532 in reported general payments places this provider in the 90th percentile of 1,137 anesthesiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anesthesiology in Savannah
- Margaret HoltzMarietta$622K
- Mark HamiltonAtlanta$351K
- Michael AshmoreAtlanta$214K
- Jessica McCabeJohns Creek$62K
- Stephen KushinsLawrenceville$62K
- Uma ShastriAtlanta$35K
- Jessica McCounRome$34K
- Amit PatelLawrenceville$17K
- Melat GebreAtlanta$16K
- Laura DowneyAtlanta$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.